The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 1
- 1 renewal
- First-year cost
- $1,999,278
- Institutions
- 1
- 1 contact PI
- Patents
- 1
- from 1 funded project
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY1
Most frequent study sections
- Special Emphasis Panel (ZCA1 GRB-I (J1))1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2014 | Adult Brain Tumor Consortium (ABTC)2UM1CA137443-06 | Grossman, Stuart A | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $1,999,278 | Study section ZCA1 |
Patents from its funded projects
1 patent names the funded project.
- US 9,731,032 (opens the patent at USPTO, a PDF, in a new tab)APTAMERS FOR TUMOR INITIATING CELLSGranted August 15, 2017 to The Cleveland Clinic FoundationUM1CA137443 · JOHNS HOPKINS UNIVERSITY, MD
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.